Ameriprise Financial Inc. Takes Position in agilon health, inc. (NYSE:AGL)

Ameriprise Financial Inc. purchased a new stake in shares of agilon health, inc. (NYSE:AGL) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 41,388 shares of the company’s stock, valued at approximately $79,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Ieq Capital LLC bought a new position in shares of agilon health during the 4th quarter valued at $26,000. Signaturefd LLC raised its holdings in agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after acquiring an additional 8,467 shares during the period. Raymond James Financial Inc. bought a new position in agilon health in the 4th quarter worth $33,000. Cerity Partners LLC bought a new position in agilon health in the 4th quarter worth $34,000. Finally, Huntington National Bank bought a new position in agilon health in the 4th quarter worth $42,000.

agilon health Price Performance

Shares of agilon health stock opened at $2.15 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm’s 50-day simple moving average is $3.57 and its 200-day simple moving average is $3.20. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73. The firm has a market cap of $890.00 million, a P/E ratio of -2.29 and a beta of 0.14.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period in the previous year, the business earned ($0.02) EPS. The firm’s revenue was down 4.5% on a year-over-year basis. As a group, research analysts expect that agilon health, inc. will post -0.59 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Sanford C. Bernstein upgraded shares of agilon health from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Needham & Company LLC reiterated a “hold” rating on shares of agilon health in a report on Friday, March 21st. Royal Bank of Canada lifted their target price on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. Citigroup upgraded shares of agilon health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $3.25 to $5.00 in a report on Friday, April 25th. Finally, Cowen reiterated a “hold” rating on shares of agilon health in a report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, agilon health has a consensus rating of “Hold” and an average price target of $4.79.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.